Andre Moore (Medication Journey)
Andre Moore’s medication journey was the long, unresolved pharmacological treatment of his severe obsessive-compulsive disorder at Patuxent Institution, an arc defined less by whether medication worked than by the standing cost of the small relief it gave him.
Overview
Andre’s medication journey was not a story of a cure, and it was not a story of failure. It was the story of a man holding an impossible question and re-asking it, dose after dose, with no clean answer available to him. The medication that quieted his obsessive-compulsive disorder did so partially, and it bought that partial quiet at a price his disorder was uniquely built to find unbearable: side effects, chiefly sweating and gastrointestinal disturbance, that made his own body generate the exact sensory experience his contamination fears categorized as filth. The pill that turned the contamination thoughts down turned the contamination reality up.
The journey was therefore a standing negotiation rather than a resolved arc. Like Jacob Keller’s treatment, Andre’s was complicated by the fact that the regimen that touched one thing aggravated another, leaving him not with a regimen that fixed his condition but with a series of regimens that failed him in different combinations. The defining feature of his experience was the recurring choice it forced on him: whether to keep taking a medication that made him feel contaminated for the sake of the modest relief it offered from feeling afraid of contamination. There was no right answer. Every dose was that question, asked again.
Background and Context
For most of his life, Andre’s obsessive-compulsive disorder was never treated because it was never recognized as illness. The system read his rituals, refusals, and panics as defiance and met them with consequences rather than care, and the record that accumulated routed him toward incarceration rather than toward a prescriber. His admission to Patuxent’s Eligible Persons Program was the first time the apparatus around him was built to read his condition correctly, and it was there, under the care of the staff psychologist Dr. Shah and the program’s psychiatric support, that pharmacological treatment finally began.
He came to it severe and braided, with contamination, checking, and symmetry compulsions firing together and compounding, and with full insight and no control. He could name precisely what his brain was doing and remained helpless to stop it. The treatment he entered combined exposure and response prevention with medication, the gold-standard pairing for severe OCD, where medication is meant to lower the disorder’s volume enough that the therapeutic work becomes possible. For Andre, the medication half of that pairing turned out to be the harder, less resolvable front.
Timeline and Phases
Phase 1: The First Trial and the Wait
Andre’s treatment began, as severe-OCD treatment generally does, with a serotonin reuptake inhibitor at doses well above the range used for depression, titrated upward over weeks toward the high target that obsessive-compulsive disorder requires. The clinical reality of this phase was a wait, and the wait was its own torment. An adequate OCD trial demands eight to twelve weeks at maximum tolerated dose before the medication can even be judged, far longer than the lag in depression treatment, and for those weeks Andre received the medication daily and could not feel it working.
For a man whose disorder already organized itself around counting, the waiting was uniquely cruel. The medication asked him to endure a void of time he could not measure his way through and could not accelerate, and his disorder filled that void with the certainty that this, too, would fail him. He counted the days the way he counted everything, and the counting gave him no relief, because the calendar offered no evidence either way until the window had passed.
Phase 2: The Contamination Cost
As the dose climbed toward the OCD target range, the side effects arrived, and they were the wrong side effects for Andre specifically. High-dose serotonergic medication commonly produces sweating and gastrointestinal disturbance, and for a man whose obsessive-compulsive disorder centered on contamination, these were not generic discomforts but a direct assault. His own body, on the medication, generated sweat and gastrointestinal distress, the precise sensory experiences his disorder read as contamination, all day, from the inside, where no washing could reach.
The gastrointestinal piece was complicated by the fact that Andre already gagged when highly anxious. Medication nausea did not create the symptom from nothing; it lowered the threshold, made his stomach less trustworthy, and gave his obsessive-compulsive disorder more material to work with. A sour stomach could trigger panic, panic could trigger gagging, gagging could make vomiting feel imminent, and the fear of vomiting fed directly into contamination, humiliation, and loss of control. Once that loop started, it was self-reinforcing in a way staff could not solve by treating it as ordinary nausea or ordinary anxiety.
This was the cruelty the whole arc turned on. The treatment did not sit outside the disease and reduce it; it climbed inside the disease and opened a new front. The thoughts grew quieter while the contamination reality grew louder, and the two could not be weighed against each other on any scale that gave him peace. The medication that was supposed to make him less afraid of being dirty was making him, by his own measure, dirtier. For a stretch, this nearly drove him off the medication entirely, and the question of whether to continue became the question the rest of the journey was built around.
Phase 3: The Balancing Act
What followed was not resolution but management, a careful and unending titration that never landed somewhere stable. Andre and his prescriber worked the regimen the way severe-OCD treatment is worked when first-line medication only partly succeeds: pushing the dose to the edge of tolerability, trying a different agent when one failed, and eventually weighing low-dose antipsychotic augmentation against the partial response a single medication could buy. Each adjustment traded one set of effects for another. None of them produced a version of Andre who was both meaningfully relieved and free of the contamination cost.
The balancing itself became dangerous territory, because the daily work of tracking the dose, monitoring the effect, weighing the sweat against the quiet, was exactly the kind of task his obsessive-compulsive disorder could colonize. Medication management, meant to be a tool, threatened to become one more thing for the disorder to ritualize. The careful balance he and the team reached was always provisional, always one bad week or one institutional disruption away from collapsing, and the question of whether the small relief was worth the contamination cost never resolved into a settled answer. Some weeks it was worth it. Some weeks it was not, and he wanted off, and the team had to walk him through the fact that going off meant losing even the modest relief and starting the agonizing wait over from the beginning.
Key Moments
The Decision to Stay On
The pivotal recurring moment of Andre’s journey was not a breakthrough but a choice he had to keep making: whether to continue a medication that made him feel contaminated for the sake of the partial quiet it gave his contamination fears. This was the hinge the entire arc rested on, and it was never decided once. It was decided weekly, sometimes daily, against the evidence of his own sweating body, and the fact that he kept choosing to stay on, through stretches where the cost felt heavier than the relief, was the closest thing the journey had to an act of courage.
The Fork: Doomed or Not Doomed
Andre read his medication the way he read his bandaged hands, as evidence. On his worst weeks, the contamination the medication generated was proof that he was doomed to his disorder, that even the cure was filth, that there was no escape because the escape itself was contaminated. On his better weeks, the partial quiet was the first evidence he had ever had that his mind was not only the enemy, that something could reach the fear and turn it down even a little. He lived on that hinge, and which side of it he stood on changed with the regimen, the dose, the week, and the sweat.
Challenges and Setbacks
The journey was non-linear by its nature, and several forces kept it that way. The side-effect contamination was the central and recurring obstacle, the thing that made every gain feel partly poisoned. The long response lag meant that any medication change reset the clock and demanded another stretch of unmeasurable waiting. Andre’s high insight offered no protection, because seeing clearly that the trade was bad did nothing to make it better; both sides of the trade were genuinely real.
The institutional context added its own instability. Continuity of psychiatric medication in carceral settings is unreliable, and even at a treatment-oriented facility like Patuxent, an interruption of a few weeks, whether from an administrative decision, a staffing gap, or a formulary review, could undo a fragile balance that had taken months to build. For a treatment whose every adjustment cost weeks of waiting, an interruption was not a pause but a demolition, sending him back to the start of a wait he had already endured.
Progress and Growth
Andre’s growth across the arc was real but quiet, and it lived in his relationship to the impossible choice rather than in any escape from it. He learned, slowly and with Dr. Shah’s help, to hold the medication question as a question he could survive without resolving, to tolerate a regimen that was good enough rather than demanding one that was clean. For a man whose disorder demanded certainty and right answers, learning to live inside a permanently unsettled trade was its own hard-won skill, and it ran parallel to the deeper work of his therapy: finding an edge between himself and his illness, and beginning, very slowly, to question the belief that he was beyond help.
Impact on Relationships
The medication journey ran alongside the relationships that anchored Andre’s life inside Patuxent. His mother Alyssa Moore, who read him better than anyone and had spent his whole life insisting he was sick rather than bad, was the person to whom the medication’s small successes meant the most, because they were the first vindication of an argument she had been making and losing for decades. Megan Alvarado and the staff who tracked his speech-rate as a meltdown gauge could read in that same rate whether a given regimen was holding or failing. And the steadying presence of Ben Keller, the one man who took Andre’s observations literally rather than reassuring him, was a different kind of medicine entirely, the kind that no titration schedule could disrupt.
Community and Peer Support
Andre navigated his medication journey largely without the peer community that often shapes such arcs. He was not in a setting with other identified OCD patients working through the same treatment, and the residents around him, however protective, did not share his specific condition or its specific pharmacological cruelties. His support came instead from his treatment team and his family rather than from peers who had walked the same path, and the absence of anyone who had endured the same contamination-cost trade left him more alone inside the choice than he might otherwise have been.
Ongoing Elements
Andre’s medication journey did not resolve, and by its nature it could not. As long as he took medication for his obsessive-compulsive disorder, the trade remained: partial relief bought at a contamination cost, a balance always provisional, a question re-asked with every dose. The arc was a journey in progress rather than a completed story, a standing negotiation that continued through his Patuxent years and beyond, with the medication remaining both a partial ally and a new contaminant, and with Andre choosing, again and again, whether the small mercy was worth the price.
Related Entries
Character Files
Key Relationships
- Alyssa Moore
- Ben Keller